LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 7 of total 7

Search options

  1. Article ; Online: Web-based formative assessment through clinical cases: role in pathophysiology teaching.

    Fernández Ros, Nerea / Lucena, Felipe / Iñarrairaegui, Mercedes / Landecho, Manuel F / Sunsundegui, Patricia / Jordán-Iborra, Carlota / Pineda, Iñigo / Quiroga, Jorge / Herrero, Jose Ignacio

    BMC medical education

    2021  Volume 21, Issue 1, Page(s) 249

    Abstract: Background: Active learning strategies such as formative assessment through clinical cases may help to get a deeper learning. We have studied the effect of this kind of online formative assessment in pathophysiology teaching.: Methods: Seven brief ... ...

    Abstract Background: Active learning strategies such as formative assessment through clinical cases may help to get a deeper learning. We have studied the effect of this kind of online formative assessment in pathophysiology teaching.
    Methods: Seven brief clinical cases were used to give formative assessment in the first semester of a pathophysiology course. To evaluate its effect on learning, we analyzed the proportion of students that passed the end of semester exam with a score above 60 over 100. We also analyzed the effect of the intervention according to the students' previous academic performance.
    Results: Ninety-six students participated in the study and sat the exam. Sixty-five of them passed it. Students that passed the exam had a higher previous academic performance and had done a higher number of exercises of formative assessment, both in univariate and multivariate analysis. The participants were divided in three groups, according to their previous academic performance. In the intermediate group, the number of cases done by the students who passed the exam was significantly higher than in those who did not pass it (median: 4 versus 0; P = 0.009).
    Conclusion: Formative assessment through web-based clinical cases was followed by an improvement of the academic results in pathophysiology, mainly in students with intermediate performance.
    MeSH term(s) Educational Measurement ; Humans ; Internet ; Problem-Based Learning ; Teaching
    Language English
    Publishing date 2021-04-30
    Publishing country England
    Document type Journal Article
    ZDB-ID 2044473-4
    ISSN 1472-6920 ; 1472-6920
    ISSN (online) 1472-6920
    ISSN 1472-6920
    DOI 10.1186/s12909-021-02691-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Serum cholesterol predicts transplant-free survival in cirrhotic patients undergoing transjugular intrahepatic portosystemic shunt.

    Ballester, Maria Pilar / Lluch, Paloma / Tosca, Joan / Capilla, Maria / Gómez, Concepción / Moreno, Oswaldo / Jordán-Iborra, Carlota / Sunsundegui, Patricia / Argemi, Josepmaria / Guijarro, Jorge / Mínguez, Miguel

    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

    2021  Volume 53, Issue 12, Page(s) 1596–1602

    Abstract: Background: Malnutrition is frequent in patients with cirrhosis and has been associated with poor prognosis. The Model for End-stage Liver Disease (MELD) score was created to predict survival after Transjugular Intrahepatic Porto-systemic Shunt (TIPS) ... ...

    Abstract Background: Malnutrition is frequent in patients with cirrhosis and has been associated with poor prognosis. The Model for End-stage Liver Disease (MELD) score was created to predict survival after Transjugular Intrahepatic Porto-systemic Shunt (TIPS) but lacks a nutritional parameter.
    Aims: To evaluate the prognostic value of serum cholesterol in patients with cirrhosis undergoing TIPS and to develop a prognostic score to predict survival.
    Methods: An explorative cross-sectional study was conducted of cirrhotic patients undergoing TIPS from 2008 until 2019. Exclusion criteria were liver transplantation or hepatocellular carcinoma before TIPS. Risk analysis was used to compare survival according to clinical and analytical data. The diagnostic performance of serum cholesterol added to MELD was evaluated and confirmed in an external validation cohort.
    Results: The final cohort of 100 patients had a mean MELD score of 14±5 and cholesterol of 122±51 mg/dL. MELD (p < 0,05) and both cholesterol (p < 0,05) and low-density lipoprotein levels (LDL-C) (p < 0,05) were independent predictors of post-TIPS transplant-free survival with an optimal cut-off of 106 mg/dL for serum cholesterol. The combined MELD-cholesterol risk score improved diagnostic accuracy of each parameter separately, and this was confirmed in the external cohort.
    Conclusion: Serum cholesterol and LDL-C are independent predictors of transplant-free survival in cirrhotic patients undergoing TIPS. The MELD-cholesterol score slightly improved prognostic accuracy.
    Lay summary: As an objective and easily measured indicator of both nutritional status and hepatic function, serum cholesterol could be useful to predict transplant-free survival in patients with cirrhosis undergoing TIPS. It can enable health care providers to identify high-risk patients and to optimize nutritional status before TIPS.
    MeSH term(s) Aged ; Biomarkers/blood ; Cholesterol/blood ; Cross-Sectional Studies ; Female ; Graft Survival ; Humans ; Kaplan-Meier Estimate ; Liver Cirrhosis/blood ; Liver Cirrhosis/mortality ; Liver Cirrhosis/surgery ; Liver Transplantation/mortality ; Male ; Middle Aged ; Portasystemic Shunt, Transjugular Intrahepatic/adverse effects ; Retrospective Studies
    Chemical Substances Biomarkers ; Cholesterol (97C5T2UQ7J)
    Language English
    Publishing date 2021-05-27
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1459373-7
    ISSN 1878-3562 ; 1125-8055
    ISSN (online) 1878-3562
    ISSN 1125-8055
    DOI 10.1016/j.dld.2021.04.035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT.

    de la Torre-Aláez, Manuel / Jordán-Iborra, Carlota / Casadei-Gardini, Andrea / Bilbao, José Ignacio / Rodriguez-Fraile, Macarena / Sancho, Lidia / D'Avola, Delia / Herrero, José Ignacio / Iñarrairaegui, Mercedes / Sangro, Bruno

    Cardiovascular and interventional radiology

    2020  Volume 43, Issue 8, Page(s) 1165–1172

    Abstract: Purpose: In patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib, post-progression survival (PPS) is marked by the pattern of progression. Our aim was to assess the influence of the pattern of progression to selective internal ... ...

    Abstract Purpose: In patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib, post-progression survival (PPS) is marked by the pattern of progression. Our aim was to assess the influence of the pattern of progression to selective internal radiotherapy (SIRT) in PPS among patients with HCC.
    Methods: A retrospective analysis of patients treated with SIRT between 2003 and 2015 was conducted, excluding those with a single nodule < 5 cm or with metastases. Four patterns of progression to SIRT were defined: target tumour growth, non-target tumour growth, new intrahepatic disease, and new extrahepatic disease. PPS was calculated from the time of progression based on RECIST 1.1 criteria.
    Results: Out of the 102 patients who met the selection criteria, 76 progressed after a median follow-up of 15 months. Median PPS was 6.5 months (95% CI 3.8-9.3 months). Patients who progressed at pre-existing lesions had a better PPS (median 12.5 months) than those who progressed with new lesions inside or outside the liver (median 4.2 months) (p = 0.02). In a Cox model adjusted by liver function and systemic inflammation, the pattern of progression had a hazard ratio of 1.64 (95% CI 0.92-2.93; p = 0.093).
    Conclusion: In a cohort of HCC patients treated with SIRT, the pattern of progression associated with worst survival was the development of new intrahepatic lesions or extrahepatic metastases.
    MeSH term(s) Aged ; Brachytherapy/methods ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/radiotherapy ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Liver Neoplasms/mortality ; Liver Neoplasms/radiotherapy ; Male ; Middle Aged ; Retrospective Studies ; Spain/epidemiology ; Survival Analysis ; Treatment Outcome
    Language English
    Publishing date 2020-03-12
    Publishing country United States
    Document type Journal Article
    ZDB-ID 603082-8
    ISSN 1432-086X ; 0342-7196 ; 0174-1551
    ISSN (online) 1432-086X
    ISSN 0342-7196 ; 0174-1551
    DOI 10.1007/s00270-020-02444-2
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients.

    Recalde-Zamacona, Borja / García-Tobar, Laura / Argueta, Alan / Álvarez, Laura / De Andrea, Carlos Eduardo / Fernández Alonso, Mirian / Ezponda, Ana / Carmona Torre, Francisco / Jordán Iborra, Carlota / Quiroga, Jorge Augusto / Del Pozo, Jose Luis / Zulueta, Javier J / Echarri, Gema / Landecho, Manuel F / Lozano, Maria Dolores

    Thorax

    2020  Volume 75, Issue 12, Page(s) 1116–1118

    Abstract: In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows ... ...

    Abstract In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows features of acute and organising diffuse alveolar damage. Subtle cellular inflammatory infiltrate has been found in line with the cytokine storm theory. Medium-size vessel thrombi were frequent, but capillary thrombi were not present. Despite the elevation of biochemical markers of cardiac injury, little histopathological damage could be confirmed. Viral RNA from paraffin sections was detected at least in one organ in 90% patients.
    MeSH term(s) Biopsy ; COVID-19/diagnosis ; COVID-19/epidemiology ; Humans ; Lung/diagnostic imaging ; Pandemics ; SARS-CoV-2 ; Spain/epidemiology ; Tomography, X-Ray Computed/methods
    Keywords covid19
    Language English
    Publishing date 2020-08-24
    Publishing country England
    Document type Journal Article
    ZDB-ID 204353-1
    ISSN 1468-3296 ; 0040-6376
    ISSN (online) 1468-3296
    ISSN 0040-6376
    DOI 10.1136/thoraxjnl-2020-215577
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: The effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with non-severe COVID-19: A pilot, double-blind, placebo-controlled, randomized clinical trial.

    Chaccour, Carlos / Casellas, Aina / Blanco-Di Matteo, Andrés / Pineda, Iñigo / Fernandez-Montero, Alejandro / Ruiz-Castillo, Paula / Richardson, Mary-Ann / Rodríguez-Mateos, Mariano / Jordán-Iborra, Carlota / Brew, Joe / Carmona-Torre, Francisco / Giráldez, Miriam / Laso, Ester / Gabaldón-Figueira, Juan C / Dobaño, Carlota / Moncunill, Gemma / Yuste, José R / Del Pozo, Jose L / Rabinovich, N Regina /
    Schöning, Verena / Hammann, Felix / Reina, Gabriel / Sadaba, Belen / Fernández-Alonso, Mirian

    EClinicalMedicine

    2021  Volume 32, Page(s) 100720

    Abstract: Background: Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomized, ... ...

    Abstract Background: Ivermectin inhibits the replication of SARS-CoV-2 in vitro at concentrations not readily achievable with currently approved doses. There is limited evidence to support its clinical use in COVID-19 patients. We conducted a Pilot, randomized, double-blind, placebo-controlled trial to evaluate the efficacy of a single dose of ivermectin reduce the transmission of SARS-CoV-2 when administered early after disease onset.
    Methods: Consecutive patients with non-severe COVID-19 and no risk factors for complicated disease attending the emergency room of the Clínica Universidad de Navarra between July 31, 2020 and September 11, 2020 were enrolled. All enrollments occurred within 72 h of onset of fever or cough. Patients were randomized 1:1 to receive ivermectin, 400 mcg/kg, single dose (
    Findings: All patients recruited completed the trial (median age, 26 [IQR 19-36 in the ivermectin and 21-44 in the controls] years; 12 [50%] women; 100% had symptoms at recruitment, 70% reported headache, 62% reported fever, 50% reported general malaise and 25% reported cough). At day 7, there was no difference in the proportion of PCR positive patients (RR 0·92, 95% CI: 0·77-1·09,
    Interpretation: Among patients with non-severe COVID-19 and no risk factors for severe disease receiving a single 400 mcg/kg dose of ivermectin within 72 h of fever or cough onset there was no difference in the proportion of PCR positives. There was however a marked reduction of self-reported anosmia/hyposmia, a reduction of cough and a tendency to lower viral loads and lower IgG titers which warrants assessment in larger trials.
    Funding: ISGlobal, Barcelona Institute for Global Health and Clínica Universidad de Navarra.
    Language English
    Publishing date 2021-01-19
    Publishing country England
    Document type Journal Article
    ISSN 2589-5370
    ISSN (online) 2589-5370
    DOI 10.1016/j.eclinm.2020.100720
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Histopathological findings in fatal COVID-19 severe acute respiratory syndrome: preliminary experience from a series of 10 Spanish patients

    Recalde-Zamacona, Borja / García-Tobar, Laura / Argueta, Alan / Álvarez, Laura / De Andrea, Carlos Eduardo / Fernández Alonso, Mirian / Ezponda, Ana / Carmona Torre, Francisco / Jordán Iborra, Carlota / Quiroga, Jorge Augusto / Del Pozo, Jose Luis / Zulueta, Javier J / Echarri, Gema / Landecho, Manuel F / Lozano, Maria Dolores

    Thorax

    Abstract: In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows ... ...

    Abstract In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows features of acute and organising diffuse alveolar damage. Subtle cellular inflammatory infiltrate has been found in line with the cytokine storm theory. Medium-size vessel thrombi were frequent, but capillary thrombi were not present. Despite the elevation of biochemical markers of cardiac injury, little histopathological damage could be confirmed. Viral RNA from paraffin sections was detected at least in one organ in 90% patients.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #729415
    Database COVID19

    Kategorien

  7. Article ; Online: Histopathological findings in fatal COVID-19 severe acute respiratory syndrome

    Recalde-Zamacona, Borja / García-Tobar, Laura / Argueta, Alan / Álvarez, Laura / De Andrea, Carlos Eduardo / Fernández Alonso, Mirian / Ezponda, Ana / Carmona Torre, Francisco / Jordán Iborra, Carlota / Quiroga, Jorge Augusto / Del Pozo, Jose Luis / Zulueta, Javier J / Echarri, Gema / Landecho, Manuel F / Lozano, Maria Dolores

    Thorax

    preliminary experience from a series of 10 Spanish patients

    2020  , Page(s) thoraxjnl–2020–215577

    Abstract: In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows ... ...

    Abstract In December 2019, an outbreak of severe acute respiratory syndrome associated to SARS-CoV2 was reported in Wuhan, China. To date, little is known on histopathological findings in patients infected with the new SARS-CoV2. Lung histopathology shows features of acute and organising diffuse alveolar damage. Subtle cellular inflammatory infiltrate has been found in line with the cytokine storm theory. Medium-size vessel thrombi were frequent, but capillary thrombi were not present. Despite the elevation of biochemical markers of cardiac injury, little histopathological damage could be confirmed. Viral RNA from paraffin sections was detected at least in one organ in 90% patients.
    Keywords Pulmonary and Respiratory Medicine ; covid19
    Language English
    Publisher BMJ
    Publishing country uk
    Document type Article ; Online
    ZDB-ID 204353-1
    ISSN 1468-3296 ; 0040-6376
    ISSN (online) 1468-3296
    ISSN 0040-6376
    DOI 10.1136/thoraxjnl-2020-215577
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top